Changes in clinical features and long-term prognosis in patients with pheochromocytoma
- PMID: 10678269
- DOI: 10.1016/s0895-7061(99)00139-9
Changes in clinical features and long-term prognosis in patients with pheochromocytoma
Abstract
To investigate changes in preoperative clinical features and the long-term outcome of tumor recurrence, mortality, and morbidity in patients with pheochromocytoma, we retrospectively examined changes in the clinical features by comparing 49 patients from 1957 to 1985 (group I) with 46 patients from 1986 to December 1995 (group II). In addition in these 95 patients (excluding 2 who had died before operation), we evaluated long-term postoperative outcome from the initial operation to August 1996 (909 patient-years). The mean age in group II was older than that of group I. The percentage of patients having proteinuria or hypertensive retinopathy in group II was less than that in group I. Of 20 patients with incidentally discovered pheochromocytoma, 7 (35%) were > or =60 years old, 7 asymptomatic, and 11 (55%) normotensive. Plasma and urinary catecholamines in these patients were significantly (P < .01) lower than in patients with pheochromocytoma having typical clinical features. Long-term cohort study showed 14 deaths. Relative survival rates were 91% at 5 years and 83% at 10 years and unchanged thereafter. The Kaplan-Meier estimate of pheochromocytoma-free survival was shorter in patients with a larger-than-median (60 g) tumor weight. Six patients had malignant recurrence 3 to 101 months (median, 45 months) after the initial operation. Of 65 patients confirmed alive at follow-up, 11 were hypertensive. In the Cox model, hypertension-free survival was not associated with age, a family history of hypertension, duration of hypertension, or creatinine clearance. Pheochromocytoma should be diagnosed from a wide spectrum of clinical features including those that are not generally suspected of resulting from excess catecholamines or hypertension, and after surgery, patients with this disease should be followed-up carefully for a long period (at least 10 years) because of the risk of tumor recurrence and the high prevalence of disease.
Similar articles
-
Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma.Endocr Relat Cancer. 2008 Dec;15(4):1127-33. doi: 10.1677/ERC-08-0049. Epub 2008 Sep 29. Endocr Relat Cancer. 2008. PMID: 18824558
-
Long-term outcome of a large series of patients surgically treated for pheochromocytoma.J Intern Med. 2005 Jul;258(1):55-66. doi: 10.1111/j.1365-2796.2005.01504.x. J Intern Med. 2005. PMID: 15953133
-
Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome.J Clin Endocrinol Metab. 2015 Dec;100(12):4498-504. doi: 10.1210/jc.2015-3045. Epub 2015 Oct 9. J Clin Endocrinol Metab. 2015. PMID: 26451910 Free PMC article.
-
Incidental adrenal pheochromocytoma. Report on 5 operated patients and update of the literature.Arch Ital Urol Androl. 2003 Dec;75(4):217-25. Arch Ital Urol Androl. 2003. PMID: 15005498 Review.
-
Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.Arch Surg. 2006 Dec;141(12):1199-205; discussion 1205. doi: 10.1001/archsurg.141.12.1199. Arch Surg. 2006. PMID: 17178962 Review.
Cited by
-
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.Ann Surg Oncol. 2020 May;27(5):1329-1337. doi: 10.1245/s10434-020-08220-3. Epub 2020 Feb 28. Ann Surg Oncol. 2020. PMID: 32112212 Free PMC article. Review.
-
Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients.Front Endocrinol (Lausanne). 2024 Aug 21;15:1419028. doi: 10.3389/fendo.2024.1419028. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39234504 Free PMC article.
-
Normal life expectancy for paraganglioma patients: a 50-year-old cohort revisited.Skull Base. 2011 Nov;21(6):385-8. doi: 10.1055/s-0031-1287681. Skull Base. 2011. PMID: 22547965 Free PMC article.
-
Multidisciplinary approach for patients with functional and non-functional adrenal masses and review of the literature.Health Sci Rep. 2017 Dec 20;1(3):e22. doi: 10.1002/hsr2.22. eCollection 2018 Mar. Health Sci Rep. 2017. PMID: 30623061 Free PMC article.
-
Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.Endocr Pathol. 2005 Spring;16(1):23-32. doi: 10.1385/ep:16:1:023. Endocr Pathol. 2005. PMID: 16000843
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical